Showing results (31-40 of 101) with videos related to
Sort By:
Pageof 11
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 10, 1995
[Alpha 1-antitrypsin deficiency--not only pulmonary and hepatic involvement]E Berge, I Os, F Skjørten, et al.Journal of Internal Medicine|March 12, 2002
Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?I Os, S Djurovic, I Seljeflot, et al.Clinical Nephrology|September 19, 2009
Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failureI Manner, S Sagedal, M Røger, et al.Psychotherapy and Psychosomatics|January 1, 1995
A double-blind study of psychosocial factors in 40-year-old women with essential hypertensionG Nordby, O Ekeberg, S Knardahl, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 17, 1998
[Pregnancy, essential hypertension and chronic renal disease]I Os, K S Andersson, P Oian, et al.American Journal of Hypertension|May 1, 1995
Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal womenG Nordby, A Moan, S E Kjeldsen, et al.Thrombosis and Haemostasis|July 15, 2000
Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery diseaseI Seljeflot, H Arnesen, A E Hofstad, et al.Cardiology|January 1, 1995
Hypertension therapy and risk of coronary heart disease: how do antihypertensives affect metabolic factors?A Moan, I Os, I Hjermann, et al.American Journal of Hypertension|August 1, 1997
Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study GroupI Os, T Hotnes, J Dollerup, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 10, 1994
[Antihypertensive treatment and risk of coronary disease. How significant is the antihypertensive effect for metabolic factors?]A Moan, I Os, I Hjermann, et al.Pageof 11